MMCM
TMO icon

Murphy & Mullick Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Murphy & Mullick Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$182K Sell
363
-1
-0.3% -$480 0.11% 148
2026
Q1 		$179K Hold
364
– – 0.13% 145
2025
Q4 		$211K Buy
364
+1
+0.3% +$566 0.15% 133
2025
Q3 		$176K Hold
363
– – 0.13% 155
2025
Q2 		$169K Hold
363
– – 0.14% 145
2025
Q1 		$181K Hold
363
– – 0.17% 120
2024
Q4 		$189K Buy
+363
New +$200K 0.17% 118

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Murphy & Mullick Capital Management's TMO Position: Q2 2026 in Review

Murphy & Mullick Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 0.27% in Q2 2026, selling an estimated $480 and leaving 363 shares worth $182K. The position accounts for 0.11% of the portfolio, ranked #148.

Murphy & Mullick Capital Management first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. The position peaked at $211K in Q4 2025. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Murphy & Mullick Capital Management held 363 shares of Thermo Fisher Scientific worth $182K as of Q2 2026.
  • Murphy & Mullick Capital Management sold 1 Thermo Fisher Scientific share in Q2 2026, an estimated $480.
  • Thermo Fisher Scientific made up 0.11% of Murphy & Mullick Capital Management's portfolio in Q2 2026, its #148 holding.
  • Murphy & Mullick Capital Management first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
  • Murphy & Mullick Capital Management's Thermo Fisher Scientific position peaked at $211K in Q4 2025.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.